TRDA icon

Entrada Therapeutics
TRDA

Overview Fund Trends Analyst Outlook Journalist POV

46 hedge funds and large institutions have $434M invested in Entrada Therapeutics in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
46
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$80.5M
2
+$75.8M
3
+$75.5M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$52.8M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$34.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$237K
27
$234K
28
$232K
29
$190K
30
$171K
31
$95K
32
$91K
33
$86K
34
$83K
35
$71K
36
$60K
37
$48K
38
$42K
39
$41K
40
$35K
41
$32K
42
$15K
43
$12K
44
$5K
45
$4K
46
$4K
1
2